These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 18355237)

  • 21. Effects of vibegron, a novel β
    Maruyama I; Yamamoto S; Tsuchioka K; Yamazaki T
    Eur J Pharmacol; 2020 Jul; 878():173096. PubMed ID: 32259514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severity of lower urinary tract symptoms reflects different composition of bladder storage dysfunction and bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia.
    Jhang JF; Liao CH; Kuo HC
    Int J Clin Pract; 2014 Jun; 68(6):743-8. PubMed ID: 24471413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
    Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I
    BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
    Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
    BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alfuzosin for the treatment of storage symptoms suggestive of overactive bladder.
    Cho KJ; Kim JC
    Expert Opin Pharmacother; 2012 Jun; 13(8):1143-51. PubMed ID: 22594844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology and impact of urinary incontinence, overactive bladder, and other lower urinary tract symptoms: results of the EPIC survey in Russia, Czech Republic, and Turkey.
    Kogan MI; Zachoval R; Ozyurt C; Schäfer T; Christensen N
    Curr Med Res Opin; 2014 Oct; 30(10):2119-30. PubMed ID: 24932562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can we predict and manage persistent storage and voiding LUTS following bladder outflow resistance reduction surgery in men? ICI-RS 2023.
    Tarcan T; Hashim H; Malde S; Sinha S; Sahai A; Acar O; Selai C; Agro EF; Abrams P; Wein A
    Neurourol Urodyn; 2024 Aug; 43(6):1447-1457. PubMed ID: 38477358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms: results of Korean EPIC study.
    Lee YS; Lee KS; Jung JH; Han DH; Oh SJ; Seo JT; Lee JG; Park HS; Choo MS
    World J Urol; 2011 Apr; 29(2):185-90. PubMed ID: 19898824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the Chinese traditional prescription Suo Quan Wan on TRPV1 expression in the bladder of rats with bladder outlet obstruction.
    Lai H; Tan B; Liang Z; Yan Q; Lian Q; Wu Q; Huang P; Cao H
    BMC Complement Altern Med; 2015 Dec; 15():424. PubMed ID: 26627190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of symptoms with urodynamic findings in men with overactive bladder syndrome.
    Al-Zahrani AA; Gajewski JB
    BJU Int; 2012 Dec; 110(11 Pt C):E891-5. PubMed ID: 22928556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Place of overactive bladder in male lower urinary tract symptoms.
    Yamaguchi O; Aikawa K; Shishido K; Nomiya M
    World J Urol; 2009 Dec; 27(6):723-8. PubMed ID: 19705127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LUTS treatment: future treatment options.
    Andersson KE
    Neurourol Urodyn; 2007 Oct; 26(6 Suppl):934-47. PubMed ID: 17696154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of female voiding dysfunction: a prospective, multi-center study.
    Choi YS; Kim JC; Lee KS; Seo JT; Kim HJ; Yoo TK; Lee JB; Choo MS; Lee JG; Lee JY
    Int Urol Nephrol; 2013 Aug; 45(4):989-94. PubMed ID: 23722818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invasively estimated International Continence Society obstruction classification versus noninvasively assessed bladder outlet obstruction probability in treatment recommendation for LUTS suggestive of BPH.
    Boormans JL; van Venrooij GE; Boon TA
    Urology; 2007 Mar; 69(3):485-90. PubMed ID: 17382150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Female bladder outlet obstruction: Common symptoms masking an uncommon cause.
    Malde S; Solomon E; Spilotros M; Mukhtar B; Pakzad M; Hamid R; Ockrim J; Greenwell T
    Low Urin Tract Symptoms; 2019 Jan; 11(1):72-77. PubMed ID: 28990728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
    Silva J; Silva CM; Cruz F
    Curr Opin Urol; 2014 Jan; 24(1):21-8. PubMed ID: 24231531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urodynamic pattern distribution among aged male patients with lower urinary tract symptoms suggestive of bladder outlet obstruction.
    Xu D; Cui X; Qu C; Yin L; Wang C; Chen J
    Urology; 2014 Mar; 83(3):563-9. PubMed ID: 24373318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overactive bladder and outlet obstruction in men.
    Chung DE; Sandhu JS
    Curr Urol Rep; 2011 Feb; 12(1):77-85. PubMed ID: 21125358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent Urinary Tract Infections in Females and the Overlap with Overactive Bladder.
    Nik-Ahd F; Lenore Ackerman A; Anger J
    Curr Urol Rep; 2018 Sep; 19(11):94. PubMed ID: 30215140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.